scispace - formally typeset
D

Donald Eagland

Researcher at University of Bradford

Publications -  29
Citations -  336

Donald Eagland is an academic researcher from University of Bradford. The author has contributed to research in topics: Vinyl alcohol & Aqueous solution. The author has an hindex of 10, co-authored 29 publications receiving 316 citations.

Papers
More filters
Journal ArticleDOI

Poly(vinyl alcohol) hydrogel as a biocompatible viscoelastic mimetic for articular cartilage.

TL;DR: The present results indicate that hydrogel materials with potential therapeutic benefit for injured and diseased joints can be engineered with surfaces with biomechanical properties similar to those of native tissue and are accepted as such by their constituent cell type.
Journal ArticleDOI

Complexation between polyoxyethylene and polymethacrylic acid—the importance of the molar mass of polyoxyethylene

TL;DR: The effect of the molar mass of polyoxyethylene, POE, upon the mechanism of complexation with polymethacrylic acid, PMAA, has been examined, using pH, density, calorimetric and cloud point studies as discussed by the authors.
Patent

Method for reducing the viscosity of viscous fluids

TL;DR: In this article, a viscous fluid, such as heavy crude oil which is too viscous to enable it to be pumped from a flowing phase of a reservoir into and along a pipeline for delivery to a refinery or other storage facility, may be contacted with a formulation to reduce its viscosity.
Journal ArticleDOI

The influence of hydration upon the potential at the shear plane (zeta potential) of a hydrophobic surface in the presence of various electrolytes

TL;DR: In this article, streaming potential results at a polyvinylacetate/water interface in the presence of LiCl, LiBr, LiI, Li 2 SO 4, NaCl, KCl, CsCl, Me 4 NCl, Et 4 NCL, and Bu 4 Ncl are presented; the data suggest a cation dependent yield stress within the liquid contained in the diaphragm pores.
Journal ArticleDOI

Recombinant Lucilia sericata chymotrypsin in a topical hydrogel formulation degrades human wound eschar ex vivo.

TL;DR: A recombinant L. sericata chymotrypsin and hydrogel formulation could represent a pragmatic alternative to larval therapy for the management of chronic wounds.